iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
170.74
-0.66 (-0.39%)
Jan 13, 2026, 1:00 PM EST - Market open

IBB Holdings Information

IBB is an equity ETF with a total of 265 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.65%, Gilead Sciences at 7.78%, Amgen at 7.64%, Regeneron Pharmaceuticals at 6.96%, and Alnylam Pharmaceuticals at 4.47%.

Total Holdings
265
Top 10 Percentage
48.60%
Asset Class
Equity
ETF Category
Health
Assets
8.59B
PE Ratio
23.95

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1VRTXVertex Pharmaceuticals Incorporated8.65%1,596,908
2GILDGilead Sciences, Inc.7.78%5,502,485
3AMGNAmgen Inc.7.64%2,004,368
4REGNRegeneron Pharmaceuticals, Inc.6.96%748,391
5ALNYAlnylam Pharmaceuticals, Inc.4.47%959,705
6INSMInsmed Incorporated3.20%1,555,427
7ARGXargenx SE2.76%299,343
8NTRANatera, Inc.2.66%971,374
9BIIBBiogen Inc.2.37%1,083,135
10ONCBeOne Medicines AG2.11%534,767
11ILMNIllumina, Inc.1.81%1,098,411
12INCYIncyte Corporation1.79%1,436,215
13UTHRUnited Therapeutics Corporation1.73%307,198
14RVMDRevolution Medicines, Inc.1.69%1,222,571
15GMABGenmab A/S1.46%3,636,562
16MEDPMedpace Holdings, Inc.1.16%167,123
17NBIXNeurocrine Biosciences, Inc.1.14%717,974
18IONSIonis Pharmaceuticals, Inc.1.10%1,174,824
19BBIOBridgeBio Pharma, Inc.1.10%1,216,932
20MRNAModerna, Inc.1.03%2,563,379
21EXELExelixis, Inc.0.99%1,920,414
22BMRNBioMarin Pharmaceutical Inc.0.96%1,400,045
23CRLCharles River Laboratories International, Inc.0.93%359,775
24MDGLMadrigal Pharmaceuticals, Inc.0.92%152,543
25TECHBio-Techne Corporation0.87%1,138,663
Showing 25 of 265 holdings
Subscribe to see the full list
As of Jan 9, 2026